Nomen is responsible for creating the name and the global identity of this world player following the merger of BioAlliance Pharma, French specialist in the development of orphan oncology drugs and Danish TopoTarget.
Onxeo finds its origins in the words oncology and orphan. The technological expertise is represented by the central X and the human approach is hinted at by the diphthong –eo.
The logo stands out with the bright colours in the “X”. This central symbol
Evokes the creativity, abilityn, innovation and the meeting point between all oncology stakeholders who are committed to improving the lives of patients.